Clinical TrialsSearch results
Number of results: 830
Recruiting
- A clinical trial of Orthokeratology lenses (development code: L001) for myopia and myopic astigmatism of spherical diopter power more than -4.00D up to -6.00D
- Myopia and myopic astigmatism (spherical diopter power more than -4.00D up to -6.00D)
- Ikai Kenzo
- 2023-11-05
Recruiting
- A clinical trial to clarify the mechanism of epilepsy as seen through AMPA receptors.
- Epilepsy
- Miyazaki Tomoyuki
- 2022-08-27
Recruiting
- A clinical trial to determine the distribution of AMPA receptor density in patients with persistent cognitive sequelae after COVID-19 disease.
- Long COVID
- Eiro Tsuyoshi
- 2023-08-24
Recruiting
- A confirmatory study of TRM-270 in comparison with Seprafilm in patients with rectal cancer receiving surgery
- Rectal cancer
- Tomita Shinpei
- 2022-11-21
Recruiting
- A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients with Diabetic Macular Edema
- Diabetic Macular Edema (DME)
- Takigawa Sotaro
- 2023-10-16
Recruiting
- A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients with Neovascular Age-Related Macular Degeneration
- Neovascular Age-related Macular Degeneration (nAMD)
- Takigawa Sotaro
- 2023-10-16
Recruiting
- A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
- NASH
- Tanigawa Ryohei
- 2023-04-29
Recruiting
- A Phase 2/3, Open-label, Historical-controlled, Single-arm, Multicenter Studyto Evaluate the Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety ofRavulizumab in Children and Adolescents With Aquaporin-4 Antibody Positive(AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Neuromyelitis Optica Spectrum Disorder
- Wuebbenhorst Hiroaki
- 2022-08-09
Recruiting
- A Phase 3 study of S-217622 targeting non-hospitalized participants
- COVID-19
- Portsmouth Simon
- 2022-10-01
Recruiting
- A Phase 3 trial of perioperative pembrolizumab or enfortumab vedotin in combination with pembrolizumab in participants who are cisplatin-ineligible or decline cisplatin with Muscle-Invasive Bladder Cancer
- Muscle-invasive Bladder Cancer
- Koh Yasuhiro
- 2023-03-03